USE OF MULTIPLE SURROGATE ENDPOINTS IN ADVANCED COLORECTAL CANCER

OBJECTIVES: Regulatory and reimbursement agencies increasingly base their decisions on surrogate outcomes especially if they can be measured early compared to the final clinical endpoint. Progression free survival (PFS) has been investigated as a surrogate endpoint for overall survival (OS) in advan...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Value in health 2017-05, Vol.20 (5), p.A13
Hauptverfasser:	Elia, E, Stadler, N, Ciani, O, Taylor, R, Bujkiewicz, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy Clinical trials Colorectal cancer Colorectal carcinoma Correlation analysis Epidermal growth factor receptors Medical treatment Meta-analysis Metastases Pharmacology Survival Systematic review Uncertainty
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!